Skip to main content
. 2023 Feb 13;15(2):626. doi: 10.3390/pharmaceutics15020626

Figure 5.

Figure 5

(A), Immunohistochemistry for HIKESHI in normal prostate normal glands, Gleason pattern 3 adenocarcinoma, Gleason pattern 4 adenocarcinoma, and Gleason pattern 5 adenocarcinoma. (B) The relative intensity of the normal glands and Gleason pattern 3 groups (n = 139), Gleason pattern 4 group (n = 99), and Gleason pattern 5 group (n = 5). *** p < 0.001. (Kruskal-Wallis test) Bar: 100 μm.